Game changing tech investment

investment

Multi-million-pound investment for University spinout to adapt ‘game-changing’ technology for Lyme disease and diabetes. The team who devised ground-breaking technology to create covid tests at the height of the pandemic have joined forces with US biotech giant Innova Medical Group (IMG) to adapt the technology to develop the tests for a range of other diseases […]

Read More… from Game changing tech investment

Breast cancer differences for sexes

differences

Breast cancer differences for sexes: gaps identified in male breast cancer management and treatment. A comprehensive review of all scientific research into male breast cancer over the past 20 years has identified major differences between the male and female conditions which could have major implications for both treatment and screening. The review of all the […]

Read More… from Breast cancer differences for sexes

Loyalty card data could help to identify ovarian cancer symptoms sooner

loyalty

Loyalty card data on over-the-counter medicine purchases could help spot ovarian cancer cases earlier, an Imperial College London-led study suggests. The study of almost 300 women found that pain and indigestion medication purchases were higher in women who were subsequently diagnosed with ovarian cancer, compared to women who did not have ovarian cancer. This change […]

Read More… from Loyalty card data could help to identify ovarian cancer symptoms sooner

The first potent COQ8 inhibitor targets ubiquinone biosynthesis

The first potent COQ8 inhibitor targets ubiquinone biosynthesis: Inhibition of the COQ8 protein could be beneficial in the treatment of diseases such as cancer. COQ8 is needed for the biosynthesis of coenzyme Q, also known as ubiquinone. A new collaborative study from the University of Eastern Finland, Washington University in St. Louis, University of Wisconsin–Madison, University […]

Read More… from The first potent COQ8 inhibitor targets ubiquinone biosynthesis

Majority of patients with bowel cancer diagnosed outside of screening programmes

bowel screening

More than 70 percent of patients with bowel cancer are not diagnosed using official screening programmes meaning diagnoses are often made late, when the cancer is at an advanced stage, according to new research from the University of Surrey. Embarrassment is the biggest reason for avoiding screening. In a paper published by the Journal of […]

Read More… from Majority of patients with bowel cancer diagnosed outside of screening programmes

A quarter of men put off health issues

quarter

Bupa UK has found a quarter of men put off health issues, with 1 in 10 deliberately missing or delaying a cancer screening. Quarter of men delay seeking help for health concerns One in 10 admit to deliberately missing or delaying a cancer screening Leading doctor urges men to take control of their wellbeing, during […]

Read More… from A quarter of men put off health issues

IBMS statement on blood tube shortage

IBMS

IBMS statement on blood tube shortage: The UK’s pathology services are experiencing major disruptions to their supplies of blood test tubes due to the ‘just in time’ manufacturing model and an over reliance on a limited number of suppliers of the test tubes. Therefore, the routine maintenance closure of the Becton Dickinson factory, along with […]

Read More… from IBMS statement on blood tube shortage

Invitation to A-A Heart Rhythm Congress 2021

A-A

Arrhythmia Alliance Heart Rhythm Congress 2021 (A-A HRC 2021) — all at a touch of a button, available on-demand at a time to suit you no matter where you are in the world — is for all those interested in expanding their knowledge of cardiac arrhythmias and is worth up to 24 CPD points. A-A […]

Read More… from Invitation to A-A Heart Rhythm Congress 2021

Increasing the accuracy of early ovarian cancer detection

Increasing the accuracy of early ovarian cancer detection: A test being developed in Queensland could help to reduce the high mortality rate from ovarian cancer by dramatically improving the accuracy of early detection. University of Queensland researchers said the test had successfully detected more than 90 per cent of early ovarian cancer compared to 50 […]

Read More… from Increasing the accuracy of early ovarian cancer detection

New blood test for the diagnostics of frontotemporal dementia

frontotemporal dementia

New blood test for the diagnostics of frontotemporal dementia. A new study by researchers at the University of Eastern Finland shows for the first time that blood-based measurement of glial fibrillary acidic protein (GFAP) enables distinguishing patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals. Frontotemporal dementia is the second most […]

Read More… from New blood test for the diagnostics of frontotemporal dementia